Retracted: Lentivirus-Mediated Knockdown of Myosin VI Inhibits Cell Proliferation of Breast Cancer Cell

Abstract

Cancer Biotherapy and Radiopharmaceuticals

officially retracts the article entitled, “Lentivirus-Mediated Knockdown of Myosin VI Inhibits Cell Proliferation of Breast Cancer Cell,” by Hong Wang, Biyun Wang, Wei Zhu, and Ziang Yang, (Cancer Biother Radiopharm 2015;30(8):330–335; doi: 10.1089/cbr.2014.1759) due to incorrectly attributed or identified sequences. Several figures and text within the methods section are strikingly similar to those in other publications^1–3 and suggests that same party prepared these papers for entirely different author sets.

The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves.

References

1. Wang Z, Xu D, Gao Y, et al. Immature colon carcinoma transcript 1 is essential for prostate cancer cell viability and proliferation. Cancer Biother Radiopharm 2015;30(7):278–284; doi: 10.1089/cbr.2014.1728.

2. Zhang C, Zhang T, Song E, et al. Ribosomal protein S15A augments human osteosarcoma xell proliferation in vitro. Cancer Biother Radiopharm 2018;29(10):451–456; doi: 10.1089/cbr.2014.1698.

3. Zhao S, Chen X, Wan M, et al. Tectonic 1 is a key regulator of cell proliferation in pancreatic cancer. Cancer Biother Radiopharm 2016;31(1):7–13; doi: 10.1089/cbr.2014.1778.